Shaped support features for footwear ground-engaging members

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Nike, Inc. patent solves the following problem:

It is useful, when participating in various activities, with footwear that provides traction and stability on the surface on the activities taking place. Therefore, only the structure of the article of footwear developed in traction systems include ground engaging members to provide traction on a variety of surfaces. included in the sample cleated shoes for playing outside, like soccer, football, and baseball.

Our analysis of this patent is as follows:

Nike, Inc.’s patent US 9456659 B2 deals with Shaped support features for footwear ground-engaging members.
The present disclosure is directed to an article of footwear including a surface configured to receive a foot and a sole component fixedly attached to a lower portion of the upper. The only component may include a baseplate with a lower face and at least a first earth had members come substantially down from the lower face of the baseplate, and a former member the elongate support extending substantially downward from the lower face of the baseplate, abutting the first member country participating in a side to side, and extending horizontally from the side of the first member country participating. The first support member may have a lower face facing a first portion and a second portion, wherein each of the first part and the second part angled in different non -pinahigda orientation.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Exercise apparatus

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Cybex International, Inc. patent solves the following problem:

Exercise machine for simulating walking or running is known and used for managing the movement of the feet of a user and feet in a kind of repeated paths of travel. The user often made in an exercise to use as a walking or running machine for an extended period of time as one to 30 minutes without interruption, and do not change to another -again exercise using a different machine as a user can do in a circuit exercise protocol. The machines typically include an electrically powered mechanism that user can activate to adjust certain aspects of the machine like the kind of opposition. Running or walking machine simulation often refers to elliptical path machine designed to turn the foot pedal foot the user was directed to the pedal and the feet of the user to travel in an elliptical or arcuate path. The type of resistance exercise performance in such a machine often varies linearly with the degree of force or speed by the user into a moving mechanical parts of the equipment. The way to drive foot pedal the machine will not be regulated other than to change the shape of the ellipse. The feet travel along a different path from the back to the front than from front to back on the elliptical machine.

Our analysis of this patent is as follows:

Cybex International, Inc.’s patent US 9457230 B2 deals with Exercise apparatus.
An exercise apparatus comprising: a foot support, a user interface which includes a visual display, the feet support user movable frame back and through any one of a a plurality of complete, reproducible and different arc of a master arcuate path, the foot support connected to a selection device that enables the user to choose any one of the plurality of arch part, one or more detectors adapted to detect one or more of the force, energy or power user made up during the foot support or distance or velocity to travel on foot or support against society during the course of performance the user of all or a part of an exercise cycle, the visual display to display a visually recognizable format to one or more of the force, strength, power, distance -on, time or velocity.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method to measure medial-lateral offset relative to a mechanical axis

File for Quick & Easy Patent Protection with PowerPatent.

The Orthosensor Inc. patent solves the following problem:

Orthopedic adjustments are included in the cycle of trial and error. For example, the adjustment requires a technique that estimated alignment that the surgeon made the distal femoral cut and the proximal tibial cut based on experience, mechanical jigs, and visual alignment. Often, the proximal tibial cut is made to remove the least amount of the proximal tibia, while ensuring sufficient removal of diseased or otherwise undesirable bone. The remaining femoral cuts made to complete forming the femur to receive a femoral prosthesis. After the femoral and tibial cuts in full, the femoral prosthesis and the tibial prosthesis, or trial version of it, temporarily implanted and the surgeon reviews leg alignment. Usually, no changes were made when the foot is within a few degrees Varus or valgus mechanical axis. An insert has a bearing surface that allows articulation of foot. A set of shims can be combined with the insert. The shims are used to change the thickness of the insert. A shim and insert the combination chosen for the best subjective nature of joint activities with a full range of motion. surgeon may also bones or do soft tissue tensioning affect the load, rotation or alignment character. In general, the implant procedure made use of subjective skills of the surgeon to reach the proper foot alignment, rotation, balance, and soft tissue tensionloading.

Our analysis of this patent is as follows:

Orthosensor Inc.’s patent US 9456769 B2 deals with Method to measure medial-lateral offset relative to a mechanical axis.
A system and method for measuring medial-lateral competition with a bone exposed. bones with a joint in the muscular-skeletal system. method comprises coupling a three-axis accelerometer in a prepared bone surface of a bone. The three-axis accelerometer configured to measure the position, rotation, and competition. joint is rotated between the two points. The rotation between the two crossing points in an arc with a maximum therebetween. The joint that pivots from a surface of the bone with. In one picture, a pivot point and joint rotation with respect to a mechanical axis of joint and bone. The three-axis accelerometer to measure data points along the arch as it is rotated between the two points. Multiple paths along the arch enough data points to determine the maximum. The maximum position is used to calculate the medial-lateral bone of competition.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II)

File for Quick & Easy Patent Protection with PowerPatent.

The Institut National De La Sante Et De La Recherche Medicale (Inserm) patent solves the following problem:

Our analysis of this patent is as follows:

Institut National De La Sante Et De La Recherche Medicale (Inserm)’s patent US 9458239 B2 deals with Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type II receptor (AMHR-II).
The present invention relates to monoclonal antibodies and fragments thereof directed against the human Anti-Mllerian hormone receptor type II (AMHR-II) and their use for treating and diagnosing cancer diseases, such as ovarian range cancer.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Deveining system and device

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Laitram, L.L.C. patent solves the following problem:

To prepare the shrimp, crawfish or other animals that have a root in the alimentary canal, it is often desirable to remove the vein. Current options for deveining shrimp include manual removal, which is inefficient and time-consuming, and automated device known in the art. With manual operation, a worker must perform a number of operations to partially or completely remove the shell from the meat of shrimp, and cut the meat with shrimp way desirable to the end user. Manual vein removal is relatively time consuming and thus lead to higher costs. Moreover, the recent contacts between the workers and the shrimp can lead to contamination of shrimps. Furthermore, the process results to be less than uniform depending on individual workers to perform the operation, and the diligence of the workers process shrimp.

Our analysis of this patent is as follows:

Laitram, L.L.C.’s patent US 9456617 B2 deals with Deveining system and device.
A deveining device efficiently removes the vein from the shrimp while preserving the meat of shrimp in both form and number. Deveining device consists of a channel that has a blade extending along a section of the canal to cut back on shrimp as it rolls through the channel to expose a vein. A low root remover severs the exposed vein from the shrimp body. Nozzles spray fluid channel to maintain shrimp by the way.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Anti-C5a binding moieties with high blocking activity

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Inflarx Gmbh patent solves the following problem:

C5a is cleaved from C5 on complement activation. Among the complement activation products, C5a is one of the most potent inflammatory peptide, with a broad spectrum of functions (Guo and Ward, 2005). C5a is a glycoprotein present in the blood of healthy people with a molecular weight of 11.2 kDa. The polypeptide of C5a contains 74 amino acids, accounting for a molecular weight of 8.2 kDa while the carbohydrate portion causes approximately 3 kDa. C5a exerts its effect through the high-affinity C5a receptor (C5aR and C5L2) (Ward 2009). C5aR belongs to the rhodopsin family of G-protein-coupled receptor with seven transmembrane portion; C5L2 similar but not G-protein-coupled. It is now believed that C5a exerts its biological functions primarily through C5a-C5aR interaction, as in certain biological responses found in C5a-C5L2 interaction. C5aR is widely expressed in myeloid cells including neutrophils, eosinophils, basophils, and monocytes, and nonmyeloid cells in many organs, particularly the lungs and liver, indicating the importance of C5a / C5aR signaling. C5a has a variety of biological functions (Guo and Ward, 2005). C5a is a strong chemoattractant for neutrophil chemotactic activity for monocytes and macrophages. C5a causes an oxidative burst (O2 consumption) in neutrophils and enhances phagocytosis and release granular enzymes. C5a also found a vasodilator. C5a is shown to be involved in the modulation of cytokine expression from different types of cell, to improve the expression of adhesion molecules on neutrophils. It found that C5a can be very harmful when it is more than a disease settings, as it is a strong inducer and enhancer for the inflammatory response-moving stream of inflammatory chain reaction. High doses of C5a lead to nonspecific chemotactic desensitization of neutrophils, thereby causing broad act (Huber-Lang et al. 2001a).

Our analysis of this patent is as follows:

Inflarx Gmbh’s patent US 9458233 B2 deals with Anti-C5a binding moieties with high blocking activity.
The present invention relates to binding moieties that specifically binds to a conformational epitope of C5a, in particular human C5a. Preferred binding moieties of anti-C5a antibodies that bind this conformational epitope. The binding moieties described here are useful as active agents in pharmaceutical compositions for the treatment and prevention of various acute and chronic diseases, in particular acute inflammatory diseases, such as systemic inflammatory response syndrome (SIRS), and different levels of sepsis and sepsis, severe sepsis, and septic shock.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Boehringer Ingelheim International Gmbh patent solves the following problem:

CX3CR1 is a G-protein coupled integral membrane proteins, which is a chemokine receptor. It is usually expressed in cells such as monocytes, dendritic cells and T cells associated with the initiation and progression of atherosclerotic plaque. It is upregulated in monocyte oxidized lipid and mediates migration of these cells to live within the plaques. The unique ligand fractalkine (FKN) expressed on the surface of vascular endothelial and smooth muscle cells in the wound where it modulates leukocyte adhesion. Fractalkine also released into circulation the proteolytic cleavage where it acts as a chemotactic agent.

Our analysis of this patent is as follows:

Boehringer Ingelheim International Gmbh’s patent US 9458235 B2 deals with Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides.
The present invention relates to CX3CR1-binding polypeptides, in particular polypeptides comprising specific immunoglobulin domains. The invention also relates to nucleic acid encoding such polypeptides; to methods of preparing such polypeptides; to host cells expressing or capable of expressing such polypeptides; to compositions comprising such polypeptides; and the use of such polypeptides or the composition, in particular for prophylactic, therapeutic and diagnostic purposes.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Systems and methods for providing a user with a set of interactivity features locally on a user device

File for Quick & Easy Patent Protection with PowerPatent.

The Dropbox, Inc. patent solves the following problem:

As applications, video applications, and other sharing applications become more popular within the device user, the service and parts are given to these applications come with inherent limitations. For example, many in the share application requires full connectivity between the server application to share content and a user device access to the server through a local application. If the level of connectivity between the server and the device is low, for example, the ability to present / give the user the inner interrupted. Furthermore, if a user device user tries to share content with a server, some sharing capability may be affected by the level of connectivity.

Our analysis of this patent is as follows:

Dropbox, Inc.’s patent US 9462054 B2 deals with Systems and methods for providing a user with a set of interactivity features locally on a user device.
Providing a user with an interactive user interface that all can join regardless of connection status will be. In some embodiments, one or more things in could choose a user of the device user and will be queued for upload to a system within the province. The matter will be organized into one or more collections in things other things kept in a users system in the administration, like the images with the same geo-temporal characteristics . A bunch of interactivity features will be available to the user to interact with the queued up things inside. This may provide the user with seamless feel as if the matter be uploaded to the system in the direction and the user can interact with the things in the system in control, even if the upload was not finished.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Endoscopic implant system and method

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Boston Scientific Scimed, Inc. patent solves the following problem:

An anatomical view of a human stomach S and associated parts shown in FIG. 1. The esophagus E delivers food from the mouth to the proximal portion of the stomach S. The z-line or gastro-esophageal junction Z is the irregularly-shaped border between the thin tissue of the esophagus and the thicker tissue in the abdominal wall. The gastro-esophageal junction region G is the region around the distal portion of the esophagus S, the z-line, and the proximal portion of the stomach S.

Our analysis of this patent is as follows:

Boston Scientific Scimed, Inc.’s patent US 9456825 B2 deals with Endoscopic implant system and method.
Disclosed is a system for endoscopically implanting a medical implant, including an anchor, in a body cavity such as the side of the gastroesophageal junction in one stomach. The system includes one or more anchors positionable in one or more openings formed in the tissues in the body cavity, like a cutout formed in plicated body tissue. Tools expressing the positioning of anchors in the door, and for coupling a restrictor food anchors.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Balloon catheters and methods for treating paranasal sinuses

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Acclarent, Inc. patent solves the following problem:

To fully understand the invention, it is necessary to consider the anatomy and physiology of the sinus system. Fig. 4-16, showing the various steps in the process of creation, also showed the importance of the sinus anatomy. The maxillary sinus 21 lies lateral to the nasal cavity 38, under the eye orbits 23 and higher than the roof or roof of the mouth. The medial wall of the maxillary sinus forms the lateral nasal wall 44 inferiorly. The frontal sinus 35 (FIG. 16) is on the orbit and the floor that formed the frontal bones and the adjacent part of the orbit roof. The right and left sinuses directly divided interfrontal septum. The frontal sinus drains into the nasal cavity and the outflow tract is inferomedial sinus, which connects the frontonasal duct 36. Frontonasal duct 36 empties into the nasal cavity through the lateral nasal wall 44 under the middle turbinate 20.

Our analysis of this patent is as follows:

Acclarent, Inc.’s patent US 9457175 B2 deals with Balloon catheters and methods for treating paranasal sinuses.
A bunch of sinus balloon catheter for the treatment given to a patient paranasal sinus system, including dilating ready door, and natural Ostia and ducts and excising sinus cavities. It includes a balloon catheter with a bend to put on a distal portion 90 into a proximal portion and a balloon catheter that is substantially straight. The catheter has sufficient stiffness and column strength of the balloon carrying distal portion of the catheter can be pushed into the prepared opening, natural ostium or duct, or sinus demanded. The catheter has to be inflated working diameters and outer diameters should the balloon is deflated and catheter can be pushed into each prepared to open, natural ostium or duct, or sinus cavities taken. The method of using the balloon catheter to dilate ready to open to selected parts of the sinus system, to dilate natural ostia and ducts in the sinus system, and / or to dilate sinus cavity to remove them.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.